Jiuzhou Pharma Europe GmbH
Jiuzhou Pharma Europe GmbH is based in Konstanz. The company is a wholly owned European subsidiary of the Chinese company Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
As part of the international Jiuzhou Pharma Group, European GmbH's expertise is focused on CDMO services, i.e. discovery and development of processes enabling manufacturing of pharmaceutical drugs. These can be clinical development candidates or molecules already on the market. The company supports pharmaceutical and biotech companies in the development and production of pharmaceutical active ingredient compounds (APIs) and CRO-related services in Europe. The aim is to research manufacturing processes, synthesis procedures, analysis methods and regulatory issues for pharmaceutical target compounds with a strong emphasis on sustainable green chemistry solutions. This is accomplished by high-quality research in a modern and well-equipped laboratory, which is situated in Konstanz.
The services include in particular:
- Research in the development of new pharmaceutical compounds (R&D, process development), with focus on providing practical, sustainable and economical solutions
- Synthesis of APIs and pharmaceutical target compounds for research purposes
- Analytical development
- Regulatory consulting, intellectual property protection
- Discovery and development of novel chemistry that decreases environmental footprint and allows a lower-cost production
The services offered are aimed at pharmaceutical companies, biotech firms and research institutions that require CDMO services on European soil. Customers benefit from a local contact for the synthesis and analysis of pharmaceutical compounds, including regulatory expertise and IP consulting within Europe. This facilitates cooperation with Chinese or other international Jiuzhou manufacturing units and supports market entry in Europe.